Navigation Links
Computer order entry systems reduce preventable adverse drug events
Date:2/7/2012

Boston, MA Despite a national mandate to implement electronic health records and computer order entry systems (CPOE) by 2014, only approximately 30 percent of hospitals nationwide have done so and around 40 percent of hospitals in the state of Massachusetts have made this transition. New research from Brigham and Women's Hospital examined the impact of a vendor-developed CPOE in five community hospitals in Massachusetts and found that these CPOE systems are effective at reducing drug-related injury and harm. This research is published online in the Journal of General Internal Medicine.

The majority of studies that evaluate CPOE systems have been performed in academic settings with systems that have been developed internally. While these studies have demonstrated significant reductions in the rates of preventable adverse drug events (ADE), there has been no research into the effectiveness of vendor CPOE systems in a community hospital setting.

"We knew from prior research that there was potential to significantly reduce preventable ADEs at community hospitals through CPOE," said Dr. David Bates, Senior Vice President for Quality and Safety at Brigham and Women's Hospital and senior author on the study. "Our research demonstrates that this is true. We observed a 34 percent reduction in preventable ADEs overall in the community hospital setting following the implementation of a vendor CPOE system."

Researchers evaluated the impact of CPOE systems on the frequency of adverse drug events (ADE) in five community hospitals in Massachusetts between January 2005 and September 2011. Each hospital independently selected and implemented a vendor CPOE system with decision support capabilities. They looked at the incidence of preventable ADEs and the rate of potential ADEs and ADEs overall.

An ADE was defined as any drug-related injury. They were considered preventable if they were due to an error or were preventable by any means available. A non-preventable ADE was defined as any drug-related injury in which there was no error in the medication process. A potential ADE, or near miss, was defined as a medication error with the potential to cause harm to the patient, but did not actually cause injury.

Researchers observed a 34 percent reduction for preventable ADEs, but an increase of 29.5 percent in potential ADEs or near-misses following implementation of a CPOE system.

"Our study shows that while rates of preventable ADEs may fall after CPOE implementation, all sites can benefit from tracking issues found post-implementation and making changes accordingly," Bates said. "The expertise and experience of others that have previously implemented CPOE can help guide the process."

Bates and colleagues note that further research needs to be conducted to explore the safest and most effective way to implement vendor CPOE and other technology. Bates and colleagues are currently investigating the impact of clinical decision support systems on ADE rates and identifying barriers to implementation.


'/>"/>

Contact: Lori Shanks
ljshanks@partners.org
617-534-1604
Brigham and Women's Hospital
Source:Eurekalert

Related biology news :

1. From field to biorefinery: Computer model optimizes biofuel operations
2. PNNLs Olympus supercomputer advances science, saves energy
3. Computerized tool takes a bite out of traditional apple testing
4. Supercomputer seeks way to mimic mollusk shell
5. TV viewing poses greater risk than computer use for cardiovascular disease
6. Magnifying research: Scientists team together to upgrade supercomputer
7. New computer program promises to save the whales
8. VBI, Convey Computer partner to deliver technology to biomedical, life sciences researchers
9. GNS Healthcare Collaborates with NCI in New Approach to Lung Cancer; Supercomputer Analysis to Aid in Matching Targeted Drugs to Patients
10. Researchers fight cholera with computer forecasting
11. GNS Healthcare Collaborates with NCI in New Approach to Lung Cancer; Supercomputer Analysis to Aid in Matching Targeted Drugs to Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2017)...  Aware, Inc. (NASDAQ: AWRE ), a leading ... for its quarter and year ended December 31, 2016. ... $3.9 million compared to $6.9 million in the same quarter ... was $0.6 million compared to $2.6 million in the fourth ... 2016 was $0.5 million, or $0.02 per diluted share, which ...
(Date:2/8/2017)... The biometrics market has reached a ... organizations, desires to better authenticate or identify users ... challenge questions), biometrics is quickly working its way ... is driven by use cases, though there traditionally ... uses cases, with consumer-facing use cases encompassing authentication, ...
(Date:2/7/2017)... , Feb. 7, 2017   MedNet Solutions , ... entire spectrum of clinical research, is pleased to announce ... , its innovative, highly flexible and award winning eClinical ... customers. iMedNet is a proven Software-as-a-Service (SaaS) ... Data Capture (EDC), but also delivers an entire suite ...
Breaking Biology News(10 mins):
(Date:3/22/2017)... , ... March 21, 2017 , ... ... , more than tripling its goal and raising over $30,000 in the first ... that grows nutritious veggies & herbs fast, easy, and affordably, anywhere. , “Simply ...
(Date:3/22/2017)... Washington, USA, and CARDIFF, UK (PRWEB) , ... March 21, 2017 ... ... regional blood flow and tissue oxygenation, is being explored as a way to track ... near-infrared spectroscopy study on tonic pain activation by cold pressor test ,” published today ...
(Date:3/22/2017)... HACKENSACK, N.J. and PETACH TIKVAH, ... Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult ... Chaim Lebovits , Chief Executive Officer, will provide ... at Sachs Associates 2 nd Annual Neuroscience Biopartnering ... at the New York Academy of Sciences. ...
(Date:3/22/2017)... SAN FRANCISCO , March 22, 2017 /PRNewswire/ ... the fastest growing genetic information companies, today announced ... the diagnosis of Spinal Muscular Atrophy (SMA) ... the leading lethal genetic disorders among infants as ... disease in childhood. The new test, announced during ...
Breaking Biology Technology: